Can-Fite receives Japanese patent allowance for Namodenoson obesity use

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/31/2026

1. AMZN
2. RBLX
3. AAPL
4. COIN
5. RDDT
6. DXCM
7. NBIX
8. FND
9. GH
10. WU

Go back to Can-Fite receives Japanese patent allowance for Namodenoson obesity use
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 3.34 +0.06 (1.83%)
Previous Close $3.28    52 Week High $3.89 
Open $3.36    52 Week Low $1.85 
Day High $3.36    P/E N/A 
Day Low $3.34    EPS $0.00 
Volume 2,850       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High $ 
Open $41.64    52 Week Low $ 
Day High $10.08    P/E N/A 
Day Low $10.08    EPS $ 
Volume 206